BioReliance offers world-class process development and manufacturing capabilities for virus based therapeutic products (e.g. gene therapy and viral vaccines). From small scale toxicology and Phase I materials to commercial-scale manufacturing and fill-finish, our flexible facilities and dedicated staff can assure that product yields and critical timelines are met.
Our state-of-the-art facilities are well equipped to meet your gene and cell therapy manufacturing and testing needs on a global scale. Our Carlsbad (CA) and Rockville (MD) facilities represent our US Centers of Excellence in viral product manufacturing and biosafety testing, respectively – with capabilities of cGMP grade bulk virus preparation augmented by industry leading analytical testing services. Coupled with our BioReliance UK GMP Manufacturing and testing facility, we have worldwide capabilities and capacity to successfully support your projects.
Apps, Tools, Newsletters & More...
Find the latest scientific resources from Sigma-Aldrich.
Copyright © 2017 Sigma-Aldrich Co. LLC. All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission. Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich Co. LLC. Sigma-Aldrich Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany Terms | Privacy | Site Map